DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 892 filers reported holding DANAHER CORPORATION in Q1 2014. The put-call ratio across all filers is 0.37 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $618,000 | +16.4% | 4,681 | -9.1% | 0.10% | +4.2% |
| Q4 2018 | $531,000 | -0.9% | 5,150 | +4.5% | 0.10% | +14.5% |
| Q3 2018 | $536,000 | +88.7% | 4,926 | +71.5% | 0.08% | +84.4% |
| Q2 2018 | $284,000 | +1.4% | 2,872 | +0.3% | 0.04% | +2.3% |
| Q1 2018 | $280,000 | -12.8% | 2,862 | -17.2% | 0.04% | -10.2% |
| Q4 2017 | $321,000 | +8.4% | 3,455 | +0.3% | 0.05% | +8.9% |
| Q3 2017 | $296,000 | -10.8% | 3,444 | -12.3% | 0.04% | -11.8% |
| Q2 2017 | $332,000 | +27.2% | 3,926 | +28.8% | 0.05% | +24.4% |
| Q1 2017 | $261,000 | -4.0% | 3,048 | -12.7% | 0.04% | 0.0% |
| Q4 2016 | $272,000 | -6.2% | 3,490 | -5.9% | 0.04% | -8.9% |
| Q3 2016 | $290,000 | -89.0% | 3,709 | -85.8% | 0.04% | -77.3% |
| Q2 2016 | $2,633,000 | +15.4% | 26,066 | +8.4% | 0.20% | +8.8% |
| Q1 2016 | $2,281,000 | +2.9% | 24,050 | +0.8% | 0.18% | -2.7% |
| Q4 2015 | $2,216,000 | +9.4% | 23,868 | +0.4% | 0.19% | +12.0% |
| Q3 2015 | $2,026,000 | +234.9% | 23,772 | +236.8% | 0.17% | +83.5% |
| Q2 2015 | $605,000 | -14.2% | 7,059 | -14.9% | 0.09% | -11.7% |
| Q1 2015 | $705,000 | +191.3% | 8,298 | +193.5% | 0.10% | +212.1% |
| Q4 2014 | $242,000 | -1.2% | 2,827 | -12.4% | 0.03% | -2.9% |
| Q3 2014 | $245,000 | -19.4% | 3,227 | -16.6% | 0.03% | -17.1% |
| Q2 2014 | $304,000 | -12.1% | 3,871 | -16.1% | 0.04% | -2.4% |
| Q1 2014 | $346,000 | +0.6% | 4,615 | +3.7% | 0.04% | 0.0% |
| Q4 2013 | $344,000 | +13.5% | 4,450 | +1.7% | 0.04% | +7.7% |
| Q3 2013 | $303,000 | +7.8% | 4,375 | -1.5% | 0.04% | +14.7% |
| Q2 2013 | $281,000 | – | 4,441 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |